A prospective, single-center, open-label, randomized study to evaluate suppression of the pituitary-ovarian axis with three different regimens of oral contraceptive pills
Phase of Trial: Phase III
Latest Information Update: 01 Mar 2008
At a glance
- Drugs Ethinylestradiol; Ethinylestradiol/levonorgestrel
- Indications Pregnancy
- Focus Pharmacodynamics
- Sponsors Duramed Pharmaceuticals Inc
- 26 Oct 2007 Status change from in progress to completed
- 27 Aug 2007 The expected completion date for this trial is now 1 Jun 2006.
- 28 Oct 2006 New trial record.